NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

NVO

Novo Nordisk ADR

May 08 • 04:00PM ET

64.85

Dollar change -2.70
Percentage change -4.00	%

Healthcare • Drug Manufacturers - General • Denmark • NYSE

Peers: LLY MRK ABBV JNJ AMGN AZN PFE SNY BMY GSK

| Held by: AVDE PPH DFIC NUGO APIE OZEM WINN PID RVER DFAI

Scroll to Statements

Index	-	P/E	19.23	EPS (ttm)	3.37	Insider Own	0.00%	Shs Outstand	3.37B	Perf Week	-1.14%
Market Cap	218.29B	Forward P/E	13.56	EPS next Y	4.78	Insider Trans	-	Shs Float	3.37B	Perf Month	5.28%
Income	15.05B	PEG	0.99	EPS next Q	0.91	Inst Own	10.14%	Short Float	0.57%	Perf Quarter	-25.61%
Sales	43.59B	P/S	5.01	EPS this Y	26.33%	Inst Trans	-2.98%	Short Ratio	2.11	Perf Half Y	-40.90%
Book/sh	4.52	P/B	14.36	EPS next Y	19.78%	ROA	26.37%	Short Interest	19.07M	Perf Year	-47.95%
Cash/sh	1.79	P/C	36.29	EPS next 5Y	19.52%	ROE	87.53%	52W Range	57.00 - 148.15	Perf YTD	-24.61%
Dividend Est.	2.00 (3.08%)	P/FCF	15.28	EPS past 5Y	21.74%	ROI	44.25%	52W High	-56.23%	Beta	0.65
Dividend TTM	1.66 (2.56%)	Quick Ratio	0.56	Sales past 5Y	18.58%	Gross Margin	84.33%	52W Low	13.77%	ATR (14)	2.86
Dividend Ex-Date	Mar 31, 2025	Current Ratio	0.74	EPS Y/Y TTM	16.36%	Oper. Margin	45.11%	RSI (14)	46.30	Volatility	2.63% 3.34%
Employees	76302	Debt/Eq	0.86	Sales Y/Y TTM	22.74%	Profit Margin	34.52%	Recom	2.03	Target Price	102.52
Option/Short	Yes / Yes	LT Debt/Eq	0.70	EPS Q/Q	10.76%	Payout	35.93%	Rel Volume	1.33	Prev Close	67.55
Sales Surprise	1.73%	EPS Surprise	8.78%	Sales Q/Q	15.81%	Earnings	May 07 BMO	Avg Volume	9.02M	Price	64.85
SMA20	1.44%	SMA50	-9.12%	SMA200	-35.33%	Trades		Volume	12,010,144	Change	-4.00%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-17-25	Downgrade	BMO Capital Markets	Outperform → Market Perform	$64
Mar-13-25	Upgrade	Kepler	Hold → Buy
Mar-03-25	Downgrade	Stifel	Buy → Hold
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Jan-06-25	Upgrade	Bernstein	Underperform → Mkt Perform
May-30-24	Initiated	Goldman	Buy	$156
Apr-12-24	Initiated	BMO Capital Markets	Outperform	$163
Jan-23-24	Initiated	Morgan Stanley	Overweight	$120
Jan-16-24	Resumed	UBS	Neutral
Dec-01-23	Initiated	Cantor Fitzgerald	Overweight	$120
Oct-02-23	Initiated	Argus	Buy	$110
Jul-14-23	Initiated	HSBC Securities	Buy
Jul-15-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Jun-28-22	Downgrade	UBS	Neutral → Sell
Jun-27-22	Upgrade	Exane BNP Paribas	Underperform → Neutral
Jun-07-22	Upgrade	JP Morgan	Neutral → Overweight
May-31-22	Upgrade	Guggenheim	Neutral → Buy
Apr-25-22	Upgrade	Cowen	Market Perform → Outperform	$130
Apr-12-22	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Mar-16-22	Upgrade	Deutsche Bank	Hold → Buy

Show Previous Ratings

May-08-25 12:00PM	Novo Nordisk (NVO) Upgraded to Buy: Here's What You Should Know (Zacks)
11:45AM	Novo Nordisk (NVO) is a Top Dividend Stock Right Now: Should You Buy? (Zacks)
09:55AM	Does Novo Nordisk (NVO) Have the Potential to Rally 51.24% as Wall Street Analysts Expect? (Zacks)
03:06AM	Novo Nordisk AS (NVO) Q1 2025 Earnings Call Highlights: Robust Growth Amid Challenges (GuruFocus.com)
May-07-25 04:43PM	These Stocks Moved the Most Today: Alphabet, Nvidia, Super Micro, Marvell, Disney, Uber, Arista, Sarepta, Charles River, and More (Barrons.com)
04:16PM	Loading…
04:16PM	Novo Nordisk Blames Compounders As It Cuts 2025 Forecast. But Shares Jump. (Investor's Business Daily)
04:05PM	Stock market today: Dow, S&P 500, Nasdaq rise as Fed holds rates steady, Powell sticks to 'wait and see' (Yahoo Finance)
02:47PM	These Stocks Are Moving the Most Today: Alphabet, Super Micro, Marvell, Disney, Uber, Arista, Sarepta, Charles River, and More (Barrons.com)
02:13PM	Stock market today: S&P 500, Nasdaq slide as Fed holds rates steady with Powell on deck (Yahoo Finance)
02:13PM	Stock market today: Dow, S&P 500, Nasdaq waver as Fed holds rates steady, Powell flags 'uncertainty' on economy (Yahoo Finance)
02:00PM	3 major takeaways from Novo Nordisk's Q1 earnings (Yahoo Finance Video)
12:43PM	Why Novo Nordisk missed its sales estimates on weight-loss drug Wegovy: CEO (Yahoo Finance)
12:43PM	Why Novo missed its sales estimates on weight-loss drug Wegovy: CEO (Yahoo Finance)
12:05PM	Novo Nordisk A/S (NVO) Q1 2025 Earnings Call Transcript (Seeking Alpha)
11:42AM	Why Novo Nordisk Stock Popped After Earnings (Motley Fool)
11:29AM	Loading…
11:29AM	Novo Nordisk Q1 Earnings Review: Forget Revenue Miss, Buy Semaglutide Hype (Seeking Alpha)
11:18AM	Hims & Hers: Short Squeeze Or Strong Fundamentals? (Rating Downgrade) (Seeking Alpha)
11:15AM	WW Stock Plunges as WeightWatchers Files for Bankruptcy (Investopedia)
11:05AM	Novo Nordisk CEO on earnings, GLP-1 deal with CVS, manufacturing (Yahoo Finance Video)
10:29AM	Novo Nordisk Q1 Earnings Match Estimates, Revenues Rise Y/Y, Stock Up (Zacks)
09:56AM	Novo Nordisk Stock Jumps After Earnings. Compounding Markets Growth Took it By Surprise (Barrons.com)
09:31AM	Novo Nordisk Predicts Strong Second Half (Motley Fool)
09:09AM	The Zacks Analyst Blog Highlights Novo Nordisk, Honeywell International and American Tower (Zacks)
09:01AM	Novo Blames Compounders As It Cuts 2025 Forecast. Shares Jump. (Investor's Business Daily)
08:35AM	It's going to be 'put up or shut up' for Novo Nordisk's Wegovy this summer: Barclays' Emily Field (CNBC TV)
08:26AM	Novo Nordisk Shares Jump 6% as Wegovy Fuels Double-Digit Growth (GuruFocus.com)
07:58AM	5 Things to Know Before the Stock Market Opens (Investopedia)
07:42AM	Novo Nordisk cuts 2025 outlook due to compounding-hit Wegovy demand (Pharmaceutical Technology)
07:21AM	Novo Nordisk Q1 2025: One Of The Best Deals You Can Get Right Now (Seeking Alpha)
07:12AM	Novo Nordisk cuts 2025 outlook. But why are its shares rising? (Seeking Alpha)
06:50AM	Loading…
06:50AM	Novo Nordisk beats on Q1 earnings, cuts 2025 outlook (Yahoo Finance)
06:14AM	Novo Nordisk Stock Jumps Despite Full-Year Outlook Cut (Investopedia)
05:53AM	Novo Nordisk's CFO sceptical Trump executive order on drug manufacturing can cut timelines (Reuters)
05:43AM	Novo Nordisk Stock Climbs On Higher Q1 Results; Cuts FY25 Outlook (RTT News)
05:35AM	Novo Nordisk Cuts Guidance as Weight-Loss Drug Sales Slow. Why the Stock Is Jumping. (Barrons.com)
05:21AM	Novo Nordisk latest drugmaker to drop gender goals in US (Reuters)
05:02AM	Novo Nordisk: Q1 Earnings Snapshot (Associated Press Finance)
04:30AM	European markets mixed ahead of Fed's policy meeting (Seeking Alpha)
02:41AM	Hims & Hers Stock (HIMS) Falls as Cautious Outlook Blurs Massive Revenue Growth (TipRanks)
01:35AM	Novo Nordisk shares up on hopes for US Wegovy recovery after forecasts cut (Reuters)
01:30AM	Novo Nordisk's sales increased by 19% in Danish kroner and by 18% at constant exchange rates to DKK 78.1 billion in the first three months of 2025 (GlobeNewswire)
May-06-25 04:47PM	Top Analyst Reports for Novo Nordisk, Honeywell & American Tower (Zacks)
04:35PM	Leading Weight-Loss Stock, Hims & Hers, Shrugs Off Outlook Worries And Spikes 18% (Investor's Business Daily)
03:36PM	Wall Street Punishes HIMS--Right After It Lands a Blockbuster Weight Loss Deal (GuruFocus.com)
03:30PM	Jim Cramer on Novo Nordisk (NVO): "Novo Lands Knockout Deal Over Lilly" (Insider Monkey)
02:32PM	Why Hims & Hers Stock Popped Tuesday, but Eli Lilly and Novo Nordisk Dropped (Motley Fool)
12:32PM	Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership? (MarketBeat)
11:40AM	Q1 2025 Hims & Hers Health Inc Earnings Call (Thomson Reuters StreetEvents)
10:32AM	Hims & Hers Stock Jumps as Q1 Sales More Than Double (Investopedia)
10:03AM	How students at Roaring Kittys high school became top stock pickers (MarketWatch)
09:50AM	Why Novo Nordisk (NVO) is a Top Momentum Stock for the Long-Term (Zacks)
09:13AM	Top 1% Stock, Hims & Hers Health, Dives On Lackluster Outlook (Investor's Business Daily)
08:00AM	Novo Resources Releases Updated Corporate Presentation (GlobeNewswire)
08:00AM	Novo Nordisk A/S: ECO 2025 - Novo Nordisk semaglutide data shows new health benefits across serious chronic diseases (GlobeNewswire)
05:49AM	Inside Last Week's Wall Street Rally & Best-Performing ETF Areas (Zacks)
05:42AM	Best-Performing Leveraged ETFs of Last Week (Zacks)
04:33AM	Why Viking Therapeutics Stock Surged Nearly 20% Higher in April (Motley Fool)
03:07AM	Hims & Hers Health Inc (HIMS) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com)
May-05-25 09:13AM	5 Drug/Biotech Stocks Likely to Outperform Q1 Earnings Estimates (Zacks)
09:11AM	High Grade Gold Anomaly Extended at John Bull in Preparation for Drilling (GlobeNewswire)
08:50AM	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings (Zacks)
08:10AM	Pfizer Stock Up 5% Following Q1 Results: Time to Buy, Sell or Hold? (Zacks)
06:45AM	3 No-Brainer Stocks to Buy in May (Motley Fool)
05:30AM	FDA accepts Novo Nordisks NDA submission for weight management therapy (Pharmaceutical Technology)
03:05AM	With compounders out of the way, Lilly and Novo go after each other (Pharma Voice)
May-04-25 05:32PM	Is Novo Nordisk A/S (NVO) The Best Stock to Buy and Hold For 10 Years? (Insider Monkey)
04:01PM	Wall Street Brunch: Bye Bye Buffett (Seeking Alpha)
09:30AM	What is CVS? 'We are ... working through that very question' (Yahoo Finance)
06:00AM	What To Expect in the Markets This Week (Investopedia)
May-03-25 11:00AM	Ford, Disney, And AMD To Report Results Next Week (Seeking Alpha)
09:30AM	Eli Lilly's Meltdown Triggers Near Doubling Upside Potential - Reiterate Buy (Seeking Alpha)
09:00AM	Eli Lilly: Don't Overthink This Buying Opportunity (Seeking Alpha)
03:00AM	SCHD Alternative Strategy: Outperforming The S&P 500 And SCHD In 2025 (Seeking Alpha)
May-02-25 03:48PM	Novo Nordisk shares jump as FDA accepts oral Wegovy application (Investing.com) +5.53%
02:41PM	US FDA accepts Novo Nordisk's application for oral Wegovy for weight loss (Reuters)
11:55AM	Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday (Motley Fool)
11:53AM	Eli Lillys Stock Selloff Is Overdone, Analysts Say. Heres Why. (Barrons.com)
10:13AM	Eli Lilly stock sell-off was 'overrreaction': Analysts (Yahoo Finance)
10:13AM	Eli Lilly stock sell-off was 'overreaction': Analysts (Yahoo Finance)
09:00AM	Is Most-Watched Stock Novo Nordisk A/S (NVO) Worth Betting on Now? (Zacks)
07:15AM	The Top 3 Stock Picks at the World's Greatest Hedge Fund (MarketBeat)
07:00AM	9 Dividend Aristocrats Potentially Set To Soar, No Matter What Happens Next (Seeking Alpha)
06:53AM	Wall Street Breakfast Podcast: Amazon Tops Expectations, Issues Cautious Outlook (Seeking Alpha)
06:45AM	Is Novo Nordisk Stock a Buy? (Motley Fool)
May-01-25 11:51PM	Q1 2025 CVS Health Corp Earnings Call (Thomson Reuters StreetEvents)
09:05PM	The GLP-1 Saga Continues, And How (Seeking Alpha)
03:56PM	CVS stock reacts to full-year guidance, Novo Nordisk GLP-1 deal (Yahoo Finance Video)
02:42PM	Eli Lilly CEO waves off CVS-Novo Nordisk deal: 'It feels a little like last decade' (Yahoo Finance)
02:04PM	3 things we've learned from healthcare earnings (Yahoo Finance Video)
01:44PM	Lillys Q1 2025 revenue jumps 45%, but CVS shift boosts Novos Wegovy (Pharmaceutical Technology)
12:19PM	Eli Lilly slides, CVS earnings, Qualcomm's soft guidance (Yahoo Finance Video)
11:51AM	LLY's Q1 Earnings Miss, Mounjaro & Zepbound Drive Sales, Stock Down (Zacks)
11:17AM	CVS strikes a deal to offer Wegovy at a discount (Fortune)
11:12AM	Hims & Hers: Revolutionizing Healthcare (Seeking Alpha)
11:11AM	Why Novo Nordisk Stock Popped Today (Motley Fool)
10:09AM	Eli Lilly's Q1 win outweighed by Novo's CVS deal (Yahoo Finance Video)
09:41AM	CVS Stock Surges On Huge Q1 Beat Amid GLP-1 Deal With Novo Nordisk (Investor's Business Daily)
09:34AM	IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? (Zacks)
08:54AM	Eli Lilly stock slips despite earnings beat, reaffirmed 2025 guidance (Yahoo Finance)
06:30AM	CVS posts Q1 earnings beat, raises full-year guidance (Yahoo Finance)

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsvaerd, Denmark.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NVO

Novo Nordisk ADR

Upgrade your FINVIZ experience